PharmiWeb.com - Global Pharma News & Resources
17-May-2022 - 19-May-2022

Pharma Clinical 2022

The pandemic response has accelerated technology adoption in clinical trials, but we have neglected patient needs by failing to develop co-created, data-driven, standardised and accountable trial designs.
  
In the face of rethinking clinical strategy, our mission is clear: it's time to develop a better system. We must establish new industry-wide benchmarks now, leverage recent digital innovations, and ensure permanent cultural change toward patient-centric trials. If we do not act immediately, we risk losing this opportunity to rebuild patient trust.

This is why we are bringing together the world's clinical leadership at Reuters Events: Pharma Clinical 2022 (May 17-19, Virtual). We aim to define the new standards in digital and patient innovation for clinical transformation. Join 500 + clinical innovators and 40 + expert speakers to create an accountable clinical ecosystem where patient diversity, centricity and empowerment aren't just slogans - they are core principles.

Most importantly, this event is free to attend for pharma and biotech employees, as well as representatives from patient and association groups.

Our key events for 2022

Benchmark industry-wide clinical innovation: Align standards across stakeholders, establish benchmarks, maintain accountability, and set industry-wide goals to improve patient experience and trial performance

Co-creation or no creation: Create shared missions, education programmes, and centre digital advances around patients to create trial designs that work in the real world

Optimise your digital and data strategies for novel endpoints: Develop trial flexibility, design efficiency, and unique RWE endpoints through standardised and tested innovations

Data collaboration: Ensure smooth interoperable data transmissions across the company's digital innovation and health networks for streamlined trials

Evolve decentralised trials: Ensure the long-term durability of your DCT's by delivering continual technology advancements for your trials that are supported by regulators and prioritise patient needs.

Join us to achieve new standards in digital and patient innovation for clinical transformation.